Promising new HIV drug keeps virus out of cells
August 19th, 2010 - 2:41 pm ICT by ANIWashington, Aug 19 (ANI): University of Utah researchers have developed a promising new anti-HIV drug candidate, PIE12-trimer, that prevents the virus from attacking human cells.
Michael S. Kay, associate professor of biochemistry in the University of Utah School of Medicine and senior author of the study, is raising funds to begin animal safety studies, followed by human clinical trials in two to three years.
Kay believes PIE12-trimer is ideally suited for use as a vaginal microbicide (topically applied drug) to prevent HIV infection. His research group is particularly focused on preventing the spread of HIV in Africa, which has an estimated two-thirds of the world’s 33 million HIV patients according to the World Health Organization.
“We believe that PIE12-trimer could provide a major new weapon in the arsenal against HIV/AIDS. Because of its ability to block the virus from infecting new cells,
PIE12-trimer has the potential to work as a microbicide to prevent people from contracting HIV and as a treatment for HIV infected people. HIV can develop resistance rapidly to existing drugs, so there is a constant need to develop new drugs in hopes of staying ahead of the virus.” Kay said.
PIE12-trimer was designed with a unique “resistance capacitor” that provides it with a strong defense against the emergence of drug-resistant viruses.
Peptide drugs have great therapeutic potential, but are often hampered by their rapid degradation in the body. D-peptides are mirror-image versions of natural peptides that cannot be broken down, potentially leading to higher potency and longevity in the body. Despite these potential advantages, no D-peptides have yet been developed.
PIE12-trimer consists of three D-peptides (PIE12) linked together that block a “pocket” on the surface of HIV critical for HIV’s gaining entry into the cell. “Clinical trials will determine if PIE12-trimer is as effective in humans as it is in the lab,” Kay said.
Across the world, HIV occurs in many different strains and has the ability to mutate to resist drugs aimed at stopping it. Due to the high conservation of the pocket region across strains, PIE12-trimer worked against all major HIV strains worldwide, from Southeast Asia and South America to the United States and Africa.
The study has been published online by the Journal of Virology. (ANI)
- Human trials under way for new HIV vaccine - Jan 03, 2012
- State of the ART of microbicides to prevent HIV - May 24, 2010
- Cancer drug successfully purges hidden HIV virus - Mar 09, 2012
- Study offers potential new targets for novel anti-HIV drugs - Mar 26, 2011
- How HIV reactivates after entering a dormant state - Feb 27, 2011
- US scientists create HIV-resistant cells - Jul 03, 2010
- Origin of HIV transmission among male partners discovered - Feb 11, 2010
- Non-stick protein coating in semen cuts HIV infection - Sep 24, 2010
- Vaginal gel could offer protection against HIV - May 24, 2010
- Unexpected find may lead to novel ways to stop HIV - Jan 24, 2011
- Now, a test to predict HIV microbicides' safety - Jul 12, 2009
- Cellular protein that acts as receptor for Ebola virus identified - May 03, 2011
- How some people control HIV infection naturally - Nov 05, 2010
- Complete structure of HIV's outer shell revealed - Jan 20, 2011
- Virus that piggybacks on AIDS virus to beat disease developed - Mar 28, 2011
Tags: animal safety, contracting hiv, drug candidate, hiv aids, hiv drug, hiv infection, hiv patients, human cells, image versions, microbicide, mirror image, natural peptides, new drugs, new weapon, rapid degradation, safety studies, trimer, university of utah school of medicine, utah school, world health organization